Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL
Clinical trial NCT05507827 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05507827
- Sponsor
- Stanford University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-18
- Primary completion
- 2025-06-18
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.